Avastin and Tecentriq combination wins approval in China and Europe

shutterstock_405286507
Earlier this year, on 29 May, Roche announced the first approval of Avastin and Tecentriq for first-line advanced HCC by the FDA. Credit: David A Litman / Shutterstock.